共 3 条
[1]
TOXICITY PREVENTION WITH AMIFOSTINE IN PEDIATRIC OSTEOSARCOMA PATIENTS TREATED WITH CISPLATIN AND DOXORUBICIN[J] . Sergio Gallegos-Castorena,Armando Mart&iacute,nez-Avalos,Alejandro Mohar-Betancourt,Guadalupe Guerrero-Avenda&ntilde,o,Martha Zapata-Tarr&eacute,s,Aurora Medina-Sans&oacute,n.Pediatric Hematology-Oncology . 2007 (6)
[2]
Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats[J] . Takeki Uehara,Hiroshi Watanabe,Fumio Itoh,Satoshi Inoue,Hikaru Koshida,Masuhisa Nakamura,Jyoji Yamate,Toshiyuki Maruyama.Archives of Toxicology . 2005 (8)
[3]
Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study[J] . N.I Weijl,T.J Elsendoorn,E.G.W.M Lentjes,G.D Hopman,A Wipkink-Bakker,A.H Zwinderman,F.J Cleton,S Osanto.European Journal of Cancer . 2004 (11)